Raaj Medisafe India shares gave 3x plus return in 6 months
On the off chance that a financial backer had put resources into this counter at the nearby cost of 31st December 2020, its ₹1 lakh would have become ₹3.70 lakh today.
In the wake of NSE Nifty, BSE Sensex, BSE Small-cap and BSE Mid-cap lists exchanging close to its lifetime high, a lot of stocks have entered rundown of multibagger stocks in 2021. Raaj Medisafe India shares are one of the pharma stocks that has given multibagger return to its investors. The little cap stock flooded from ₹11.95 per value share levels to ₹36.95 each over the most recent half year giving more than 200% re-visitation of its investors.
This multibagger stock was feeling the squeeze last week after benefit booking trigger. The little cap pharma stock plunged 7.5 % last week subsequent to making an end high of ₹41.85 in most recent one month exchange meeting. Even in the wake of shedding close 7.5% last week, the pharma stock has conveyed heavenly 30% re-visitation of its investors in most recent one month time skyline. Over the most recent one month, this pharma stock went up from ₹28.45 per value share imprint to ₹36.95 levels. In Year to Date (YTD) terms, the stock has flooded around 270% while over the most recent one year, this stock have acquired around 200% till February 2021, this pharma stock was a penny stock citing beneath ₹10 each. Nonetheless, this stock began soaring in market rally post-second influx of Covid-19.
Following Raaj Medisafe India share value history, if a financial backer had put ₹1 lakh in this little cap pharma counter one month prior and had remained contributed till date, its ₹1 lakh would have become ₹1.30 lakh today. In the event that a financial backer had put resources into this counter at the nearby cost of 31st December 2020, its ₹1 lakh would have become ₹3.70 lakh today.
Similarly, if a financial backer had put resources into this little cap pharma stock half year prior, its ₹1 lakh would have gone to ₹3.09 lakh as the stock has given around 209% return in this period.
Post a Comment